Gufic Biosciences Ltd.

₹391.8

-2.2 (-0.6%)

GUFICBIO Share Price

Pharmaceuticals & Biotechnology

As on October 23, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,937.09 Cr

P/E Ratio61.19

Dividend Yield0.03 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	396.85	Bearish
10-DMA	404.72	Bearish
20-DMA	413.71	Bearish
50-DMA	421.28	Bearish
100-DMA	401.97	Bearish
200-DMA	350.72	Bullish

Historical Performance

1 Year

13.8%

3 Years

55.3%

5 Years

112.8%

10 Years

847.5%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024
Net Sales	9,440	8,198	8,067
Total Expenditure	7,927	6,837	6,594
Other Income	27	36	22
Operating Profit	1,540	1,397	1,495
Interest	366	245	168
Depreciation	308	211	170
Profit Before Tax	865	941	1,157
Consolidated Net Profit	642	696	861
Adjusted EPS	6	7	9

Compounded Sales Growth

10 Years:3.2

5 Years:3.2

3 Years:3.2

TTM:2.9

Compounded Profit Growth

10 Years:-5.7

5 Years:-5.7

3 Years:-5.7

TTM:-1.6

Stock Price CAGR

10 Years:23.2

5 Years:16.3

3 Years:15.8

TTM:14.7

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:8.6

last year:6.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024
Share Capital	100	100	100
Total Reserves	6,549	5,909	5,225
Long-Term Borrowings	---	---	---
Total Non-Current Liabilities	1,595	1,807	1,879
Other Current Liabilities	580	701	565
Short Term Borrowings	2,545	1,543	1,420
Total Liabilities	13,424	11,694	10,925
Capital Work in Progress	221	218	3,071
Long Term Loans & Advances	238	132	231
Currents Investments	---	---	---
Short Term Loans and Advances	1,020	625	528
Total Current Assets	8,021	6,245	6,005
Total Assets	13,424	11,694	10,925
Adjusted Book Value	66	60	53

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 61.19, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 16.8%, indicating sustained price appreciation.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹1540 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹9440 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1146619.8

No. of Shares: 2927 (Approx)

Performance:14.7%

146619.8

NIFTY Performance: -12.4%

1 day Top Gainers